Taken together, we hypothesized that the primary cause of poor prognosis of pancreatic cancer, at least in our study, was metabolic disorders caused by inadequate insulin secretion, which was fueled by neuroendocrine aberration. Here, INS is linked to pancreatic neoplasm.